Method for producing human thymosin alphal utilizing transgenic tomato
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- THE INST OF BIOTECHNOLOGY OF THE CHINESE ACAD OF AGRI SCI
- Publication Date
- 2007-01-10
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a method for producing human thymosin α1 by transgenic tomato. Background technique
[0002] Thymosin α1 (Thymosin-α1, Tα1) is a polypeptide with strong immune activity secreted by the thymus, the central immune organ of the human body. It consists of 28 amino acid residues, is rich in acidic amino acids, and is heat-stable at 80°C. The PI value of Tα1 is 4.2, and the theoretical molecular weight is 3.108kDa. It has no high-level spatial structure, no disulfide bond and glycosylation modification, and the only modification is N-terminal acetylation. Tα1 plays an important role in the body. It can promote the function of T cells, promote the production of specific antibodies and cytokines, and strengthen the immune system. Clinically, purified Tα1 can treat immunodeficiency diseases, such as lupus erythematosus, chronic hepatitis B, hepatitis C, etc. It can also be used as an auxiliary drug for the treatment of tumors and cance...